Clinical Trials Logo

Clinical Trial Summary

The aims of this project are to determine if dietary supplementation with NOPE-EGCG (PhosphoLeantm, 30mg NOPE+20mg EGCG per capsule) can:

- rescue striatal function,

- increase adherence to a diet,

- reduce weight-gain after a diet,

- improve performance on impulsivity, go/no-go tasks, and negative outcome learning, and

- shift fat and sweet preference in overweight/obese human subjects

Secondary hypotheses: Baseline brain; perceptual and cognitive measures will be associated with diet, insulin sensitivity and may vary with genotype (TaqA1 1A polymorphism).


Clinical Trial Description

In prior studies we have demonstrated an inverse relationship between body mass index and response in the dorsal striatum (DS) during consumption of a palatable milkshake (Stice et al. 2008). We have also shown that the magnitude of the reduced response predicts weight gain, especially in individuals who carry a copy of the A1 allele of the taq1A polymorphism (Stice et al. 2008). Since the A1 allele is associated with reduced striatal D2 receptors (Jonsson et al. 1999, Noble 2003, Noble et al. 1991, Pohjalainen et al. 1998, Ritchie et al. 1998, Thompson et al. 1997), this finding implicates the dopamine system in the reduced blood oxygen level dependent (BOLD) response. Our results also indicate that this reduced response is a consequence, rather than a cause of obesity, since gaining weight (Stice et al. 2010), but not risk for obesity (Stice et al. 2011) (by virtue of parental obesity), is associated with reduced DS response to palatable food. Taken together the results indicate that increased adiposity is associated with blunted DS response to palatable food that may reflect altered dopamine signaling. More recently we determined that reduced DS responses in overweight and obese subjects are associated with increased impulsivity measured with the Barratt Impulsiveness Scale and a go no/no-go task (Babbs et al, In Press).

Related to these findings in humans, preliminary work in rodents shows that exogenous administration of N-Acylethanolamines, such as oleoylethanolamine (OEA) can normalize high-fat diet induced dopamine decreases in DS and possibly induce a shift in preference (Tellez et al., In Press). Human testing of OEA supplementation is possible based on the availability of a dietary supplement containing the OEA precursor NOPE-EGCG ((PhosphoLEANtm, 100 mg NOPE+50mg EGCG per capsule). PhosphoLEAN has been shown to enhance adherence to dietary advice in overweight healthy subjects (Rondanelli et al. 2009, Mangine et al. 2012).

We therefore propose a double-blind cross-over study to test whether PhosphoLean will rescue striatal function, increase adherence to a diet, reduce weight-gain after a diet, improve performance on impulsivity, go/no-go tasks, and negative outcome learning, and shift fat and sweet preference in overweight/obese human subjects. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01976156
Study type Interventional
Source Yale University
Contact
Status Completed
Phase N/A
Start date October 2013
Completion date October 2017

See also
  Status Clinical Trial Phase
Recruiting NCT03886025 - Combined Anodal Transcranial Direct Current Stimulation (tDCS) and Cognitive Training and Decision-making N/A
Recruiting NCT03457402 - Shaping Tolerance for Delayed Rewards N/A
Recruiting NCT05383989 - The UniVenture Program N/A
Completed NCT01978431 - Impulsivity and Stimulant Administration Phase 1
Completed NCT02930642 - Food Insecurity, Obesity, and Impulsive Food Choice N/A
Completed NCT04405089 - tDCS for Impulsivity and Compulsivity in Obesity N/A
Recruiting NCT05647044 - Frontal iTBS for Impulsivity and Suicidal Ideation in Veterans With Mild Traumatic Brain Injury Phase 1
Completed NCT04167995 - Assessment of Probiotics Lactobacillus in the Management of Attention Deficit Hyperactive Disorder Early Phase 1
Completed NCT01902069 - The Gut-brain Axis in Food Reward and Alcohol Consumption N/A
Recruiting NCT05231213 - Effects of Neuromodulation and Cognitive Training for Suicide in Veterans (ENACTS) N/A
Active, not recruiting NCT03844607 - Combined tDCS and Cognitive Training to Reduce Impulsivity in Patients With Traumatic Brain Injury N/A
Completed NCT05863169 - fNIRS Neurofeedback in Highly Impulsive Participants With ROI Regions DLPFC and IFG N/A
Active, not recruiting NCT01314378 - Effects of Intensive Behavioral Training Program on Impulsivity and Inhibitory Control in Smokers N/A
Completed NCT01982422 - Developmental Origins of Attention Deficit Hyperactivity Disorder N/A
Recruiting NCT06129500 - CBT for Problematic Impulsive Behaviours in Bipolar Disorder: A Case Series / CBT-PIB N/A
Completed NCT03623477 - Can Cognitive Training Decrease Reactive Aggression? N/A
Recruiting NCT05324670 - Title: "Intervention Based on Didactic Model for Suicidal Behavior in the Framework of Impulsivity and Ideations." N/A
Withdrawn NCT01770600 - Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression N/A
Terminated NCT04781166 - An Online Intervention to Reduce Self-Harm Among Persons With High Emotion-Related Impulsivity N/A